The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Roy Herbst receives Ezra Greenspan Award from Chemotherapy+ Foundation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Roy S. Herbst (middle) receives his award at the Innovation Gala of The Chemotherapy+ Foundation, with Robert Winn (left), director and Lipman Chair in Oncology at VCU Massey Comprehensive Cancer Center, and Katerina Politi (right), scientific director of YCC’s Center for Thoracic Cancers.

Roy S. Herbst was awarded the Ezra Greenspan Award at the Innovation Gala of The Chemotherapy+ Foundation on Nov. 19 in New York City. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

2025 Dr. Eddie Méndez Scholar Award Recipients, top row left to right: Caitlin Cornell, PhD, Elizabeth Kaweesa, PhD, Leandro Fernández-García, PhD, Almudena Chaves Pérez, PhD. Bottom row left to right: Luis Cedeño-Rosario, PhD, Nicole Halmai, PhD, Megan E. Meuser, PhD, Sarah Elisabeth Pierce, PhD.  Fred Hutch Cancer Center has announced eight recipients of the 2025 Dr. Eddie Méndez Scholar Award. 
Editorial

The Cancer Letter receives nine journalism, design awards

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

By Katie Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account